SCIENCE CORP. READIES FIRST HUMAN BRAIN SENSOR

The implantable sensor could help address multiple neurological disorders if clinical trials prove successful. An early application involves delivering gentle electrical stimulation to damaged brain and spinal cord cells to promote healing. Science Corp., founded by Hodak following his departure from Neuralink, is developing brain-computer interface technology focused on therapeutic applications. The approach differs from consumer-oriented neural interfaces by prioritizing medical outcomes. The sensor represents a significant step in translating neurotechnology from research settings into clinical practice. Regulatory approval and successful human trials would validate whether electrical stimulation can effectively repair neural tissue and restore function in patients with degenerative conditions. Details on trial timelines, patient selection criteria, and specific neurological conditions targeted remain limited. The company's progress will likely influence investment and development timelines across the broader neurotech industry.